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Attention-deficit/hyperactivity disorder (ADHD [MIM 143465]) is a common, highly heritable neurobehavioral
disorder of childhood onset, characterized by hyperactivity, impulsivity, and/or inattention. As part of an ongoing
study of the genetic etiology of ADHD, we have performed a genomewide linkage scan in 204 nuclear families
comprising 853 individuals and 270 affected sibling pairs (ASPs). Previously, we reported genomewide linkage
analysis of a “first wave” of these families composed of 126 ASPs. A follow-up investigation of one region on 16p
yielded significant linkage in an extended sample. The current study extends the original sample of 126 ASPs to
270 ASPs and provides linkage analyses of the entire sample, using polymorphic microsatellite markers that define
an ∼10-cM map across the genome. Maximum LOD score (MLS) analysis identified suggestive linkage for 17p11
( ) and four nominal regions with MLS values 11.0, including 5p13, 6q14, 11q25, and 20q13. TheseMLSp 2.98
data, taken together with the fine mapping on 16p13, suggest two regions as highly likely to harbor risk genes for
ADHD: 16p13 and 17p11. Interestingly, both regions, as well as 5p13, have been highlighted in genomewide scans
for autism.
Introduction
Attention-deficit/hyperactivity disorder (ADHD [MIM
143465]) is a pervasive neurobehavioral disorder af-
fecting ∼5% of children and adolescents and ∼3% of
adults (Wolraich et al. 1996; Goldman et al. 1998; Swan-
son et al. 1998; Scahill and Schwab-Stone. 2000). A
growing body of epidemiological and clinical data in-
dicate globally similar prevalence rates across diverse
geographic and cultural settings, including studies in
Brazil, Germany, New Zealand/Australia, Turkey, the
United Kingdom, and the United States (Anderson et al.
1987; Baumgaertel et al. 1995; Wolraich et al. 1996;
Gomez et al. 1999; Rohde et al. 1999; Tahir et al. 2000;
Wilens et al. 2002). ADHD is more frequently diagnosed
in boys, with male:female ratios between 3:1 and 4:1
(Cantwell 1996; Swanson et al. 1998). ADHD is defined
by the presence of six or more symptoms of inattention
and/or hyperactivity-impulsivity that lead to significant
impairment in at least two settings and have their onset
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by age 7 years (American Psychiatric Association 1994).
Under criteria of the Diagnostic and Statistical Manual
of Mental Disorders, 4th edition (DSM-IV) (American
Psychiatric Association 1994), three subtypes are rec-
ognized: inattentive (I), hyperactive-impulsive (HI), and
combined (C), reflecting the presence of six or more
symptoms on dimensions of inattention, hyperactivity-
impulsivity, or both, respectively. Comorbidity is com-
mon in ADHD, with oppositional disorders, mood dis-
orders, anxiety, and learning disabilities being the most
prevalent conditions, likely reflecting the complexity of
the biological etiology (August and Garfinkel 1989; Pel-
ham et al. 1992; Biederman et al. 1996; Wolraich et al.
1998; Brown et al. 2001; Wilens et al. 2002).
ADHD has a significant genetic component. Data
from clinical studies consistently support the familial
nature of ADHD (Biederman et al. 1992; Faraone and
Biederman 1994). Twin studies of categorically defined
ADHD and/or continuous rating scales of hyperactivity,
impulsivity, and inattention lead to estimates of heri-
tability of ∼60%–90% (Levy et al. 1997; Smalley 1997;
Faraone and Doyle 2001) and reported sibling relative-
risk ratios (ls) of 4.0–8.0 (Smalley et al. 1997; Faraone
et al. 2000). In addition, adoption studies demonstrate
an increased frequency of ADHD diagnoses in biolog-
ical relatives of probands (Morrison and Stewart 1973;
Cantwell 1975; van den Oord et al. 1994), consistent
with genetic underpinnings. Although segregation anal-
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Table 1
ASP Families Included in Genomewide Scan
Wave 1a Wave 2 Combinedb
No. of families with:
Two affected sibs 96 86 180
Three affected sibs 6 12 18
Four affected sibs 2 3 6
Total 104 101 204
Total independent ASPsc 114 119 234
Total ASPsd 126 140e 270
a Subset of families reported elsewhere (Fisher et al. 2002).
b The number of possible ASPs in the combined set reflects the sum
of possible pairs in wave 1 and wave 2, plus an additional ASP created
from the addition of 2 affected siblings from a wave 1 family that
were collected after wave 1 was completed. The combined set includes
this ASP, while wave 2 does not, so that the families in wave 1 and
wave 2 are completely independent. Thus, in the combined data set
there is 1 additional independent ASP and 4 additional total ASPs over
and above the sum of wave 1 and wave 2.
c A family with n sibs contributes n1 independent pairs.
d A family with n sibs contributes n(n1)/2 possible pairs.
e Of these 140 ASPs, 107 were included in a previous analysis of
chromosome 16p (Smalley et al. 2002).
ysis (Deutsch et al. 1990; Faraone et al. 1992) suggested
a possible major-gene effect, there are indications of
multiple genes, with minor-to-moderate effect sizes,
from molecular studies of candidate genes (Faraone et
al. 2001) and genomewide exclusion mapping (Fisher
et al. 2002).
Molecular genetic studies have primarily focused on
candidate genes involved in catecholamine processes,
synaptic transmission, and serotonin pathways. The se-
lection of candidate genes has been driven by biological
observations, such as the treatment efficacy of stimu-
lants, and by the notion that the primary behavioral
and cognitive deficits in ADHD are related to functions
associated with the frontal-cortex and frontal-striatal
networks (Barkley 1997; Yamasake et al. 2002). How-
ever, the results from 150 candidate gene studies are
equivocal, and the effect sizes of purported susceptibility
alleles are small (Comings et al. 1995; Cook et al. 1995;
Lahoste et al. 1996; Gill et al. 1997; Smalley et al. 1998;
Daly et al. 1999; Palmer et al. 1999; Comings et al.
2000; McCracken et al. 2000; Barr et al. 2001; Curran
et al. 2001; Payton et al. 2001). Although polymor-
phisms in the dopamine D4 receptor gene (DRD4) and/
or the dopamine transporter protein (DAT-1) have
shown association in independent studies (Cook et al.
1995; Lahoste et al. 1996; Gill et al. 1997; Smalley et
al. 1998; Daly et al. 1999; Faraone et al. 2001; Mill et
al. 2001), the estimated effect sizes are small (genotype
relative risks of ∼1.5 or less), and other studies have
failed to replicate the observed associations, despite ad-
equate power (Palmer et al. 1999; Holmes et al. 2000).
The alternative and complementary strategy of ge-
nomewide linkage analysis enables the detection of sus-
ceptibility loci without any a priori knowledge regard-
ing the specific genes involved in the disease state. We
have employed an affected-sibling-pair (ASP) strategy,
with parental genotyping, and have reported elsewhere
the results of a genomewide scan in a set of 126 ASPs
(Fisher et al. 2002). Linkage analysis yielded multipoint
maximum LOD scores (MLSs) 1.0 in 12 genomic
regions, including 16p13. In a follow-up investigation
of 277 ASPs, using a dense set of microsatellite and SNP
markers on 16p, fine-mapping yielded significant link-
age (MLS 4.22; Smalley et al. 2002). Here, we present
the results of a genomewide linkage analysis (∼10-cM
density) in an extended cohort of 270 ASPs. In addition
to the linkage we previously detected on 16p13, we find
suggestive linkage for a region on 17p11 (near marker
D17S1857; MLS 2.98) and nominal support (MLS
1.0) for four genomic regions 11.0 on 5p13, 6q14,
11q25, and 20q13.
Subjects and Methods
Ascertainment and Diagnostic Procedures
Families that included at least two children with
ADHD were recruited from multiple sources, including
previous research studies of ADHD, clinics, hospitals,
and schools in the greater Los Angeles area (Smalley et
al. 2000). Families were evaluated at the University of
California, Los Angeles (UCLA), and both consent and
assent forms (approved by the UCLA institutional
review board) were signed during the initial visit. As-
sessment of psychiatric disorders was performed using
semistructured interviews, the Schedule for Affective
Disorders and Schizophrenia for School-Age Children–
Present and Lifetime version (KSADS-PL) (Kaufman et
al. 1997) for subjects 5–17 years of age and the Schedule
fo Affective Disorders and Schizophrenia–Lifetime Ver-
sion, modified for the study of anxiety disorder (Fyer et
al. 1995), with the Disruptive Disorders section of the
KSADS-PL for subjects aged18 years. Interviews were
conducted by clinical psychologists and highly trained
interviewers and were administered to themother aswell
as the child if the child was8 years of age. In addition,
the Swanson, Nolan, and Pelham, version IV (SNAP-IV)
(parent and teacher versions; Swanson 1995), the Child
Behavior Checklist, and the Teacher’s Report Form
(Achenbach 1993) were utilized to supplement infor-
mation obtained in the direct interviews. Diagnosis was
determined using a best-estimate procedure, with senior
psychiatrists (J.J.M. and J.T.M.) reviewing all positive
diagnoses. The mean weighted k for diagnoses was 0.84
( ), including values for ADHD (1.0), oppo-SDp 0.14
sitional defiant disorder (0.93), and conduct disorder
(1.0).
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Table 2
Demographics and Clinical Characteristics of 438
Affected Siblings
Characteristic
No. of Affected
Siblings (%)
Sex:
Male 315 (72)
Female 123 (28)
Ethnicity:
White 351 (80)
Latino 20 (5)
Asian 11 (3)
Othera 56 (12)
Socioeconomic statusb:
I 97 (22)
II 153 (35)
III 135 (31)
IV 46 (10)
V 7 (2)
ADHD diagnosis:
Definite 414 (95)
Probable 24 (5)
ADHD subtype:
Combinedc 211 (48)
Inattentived 196 (45)
Hyperactive-impulsivee 31 (7)
Comorbidity:
Oppositional defiant disorder 239 (45)
Conduct disorder 64 (12)
Moodf 97 (18)
Anxietyg 45 (9)
a Includes subjects whose parents are of different
ethnicities.
b According to Hollingshead (1957).
c Subjects exceed symptom thresholds in both inattentive
and hyperactive-impulsive domains.
d Subjects with inattentive ADHD exceed symptom
thresholds in the inattentive domain but not in the hyper-
active-impulsive domain.
e Subjects with hyperactive-impulsive ADHD exceed
symptom thresholds in the hyperactive-impulsive domain,
but not in the inattentive domain.
f Includes major depression, dysthymia, and/or bipolar
disorder.
g Includes two or more of the following: panic disorder,
social or simple phobia, obsessive-compulsive disorder, and/
or agoraphobia.
ADHD was diagnosed according to DSM-IV criteria
and was defined as “definite” when all criteria were met
or as “probable” when the subject met only five criteria,
instead of the six required for definite diagnosis, but was
accompanied by significant impairment. In the present
study, we have qualitatively assigned all individuals with
definite and probable diagnoses as affected, similar to
the “broad” definition used in the first genomewide scan
(Fisher et al. 2002). Families were excluded from anal-
ysis if an affected child met criteria for autism or schizo-
phrenia. Full-scale IQ was measured using the Wechsler
Intelligence Scale for Children, 3rd edition (Wechsler
1991), and academic achievement was determined us-
ing the Peabody Individual Achievement Test–Revised
(Markwardt 1989). Affected children were excluded
from analysis if their full-scale IQ was !70. A thorough
description of the cohort and all associated procedures
has been reported elsewhere (Smalley et al. 2000).
Demographic and Clinical Characteristics
The total sample includes 204 families, comprising
270 possible ASPs and 234 independent pairs (table 1).
The initial set of 104 families, termed “wave 1,” in-
cluded 126 ASPs (Fisher et al. 2002). We extended the
sample with an additional set of 101 families, termed
“wave 2” and comprising 140 ASPs. Together, the wave
1 and wave 2 families constitute the “combined” set.
Family 580, a four-sibling family, contributed a single
ASP to both wave 1 and wave 2, because of the logistics
of data collection. The cohort is 72% male and 80%
white, with the average age of affected children being
11.1 years ( ) and the average full-scale IQ be-SDp 3.6
ing 105.9 ( ). The majority of the sample metSDp 14.2
“definite” diagnostic criteria (95%), with 24 affected
siblings classified as “probable” (5%). All ASP families
had at least one member with a definite diagnosis. As
shown in table 2, the distribution of subtypes and co-
morbid conditions in the sample is similar to that ex-
pected on the basis of clinical and epidemiological stud-
ies of ADHD.
The extended sample of 277 ASPs reported elsewhere
(Smalley et al. 2002) for fine-mapping on 16p overlaps
with the current data set by 237 ASPs. The lack of over-
lap of 73 ASPs in the fine-mapping sample and the cur-
rent sample was due to logistic issues stemming from
the timing of the genotyping efforts at the two indepen-
dent laboratories: the 10-cM markers (Wellcome Trust
Centre for Human Genetics) and fine-mapping markers
on 16p (UCLA). Specifically, 40 ASPs unique to the 16p
fine-mapping sample were not genotyped for the 10-cM
grid, and 33 ASPs included in the 10-cM genotyping
were not genotyped for the fine-mapping analyses.
Genotyping and Laboratory Procedures
Affected siblings and their parents were genotyped
with 423 polymorphic microsatellite markers, spanning
the entire human genome. Both parents were genotyped
in 188 (92%) of the 204 families, and a single parent
was genotyped in the remaining 16 families. The ma-
jority of autosomal markers represent the ABI Prism
Linkage Mapping Set (LMS) 2.5 panels, supplemented
with additional markers to compensate for large inter-
vals and/or poorly amplifying markers. X-chromosome
markers were taken from the LMS 2.5 panels and from
the Cooperative Human Linkage Center (CHLC)/Weber
Ogdie et al.: Genomewide Scan in 270 ADHD ASPs 1271
Human Screening Set version 6 (ResearchGenetics). Sex-
averaged marker maps were determined from CHLC,
Ge´ne´thon (Dib et al. 1996), Marshfield, and maps gen-
erated from recombination fractions within the sample,
using both Genehunter version 2.1 (Kruglyak et al.
1996) and ASPEX version 2.3. The average intermarker
interval was 9.2 cM. Fine-mapping data for 16p13, from
the previously published study (Smalley et al. 2002),
were combined with the present data set to present the
most complete analysis possible. The incorporated data
set consists of 10 additional markers spanning 20 cM
on 16p13, described in detail elsewhere (Smalley et al.
2002).
PCR was performed in 9-ml volumes in 96-well plates.
Each reaction contained ∼24 ng of genomic DNA, 0.2
mM MgCl2, 0.2 mM dNTPs, and 0.25 U of AmpliTaq
gold DNA polymerase (ABI). Standard thermocycling
protocols were performed in 96-well MJ Research tetrad
thermocyclers. For a minority of DNA samples with low
yields, primer extension preamplification (PEP) was per-
formed as described elsewhere (Zhang et al. 1992). PCR
products were run on ABI 3700 capillary-action se-
quencers, and trace files were analyzed in Genotyper
version 3.7. Random subsets of trace files were inde-
pendently analyzed and reviewed by both M.N.O. and
I.L.M., to ensure accurate and consistent allele desig-
nation. GAS version 2.0 (A. Young; Genotype Linkage
Analysis–GASWeb site) was used to eliminate violations
of Mendelian inheritance and to assign global allele des-
ignations. Haplotypes were generated in Genehunter
version 2.1 and all double recombinants, as well as any
chromosome with an excessive number of crossovers,
were reviewed extensively. LINKAGE format files were
generated with the use of MAKEPED and RECODE
version 1.4.
ASP Linkage Analysis
MLS analysis (Risch 1990) was performed under a
multiplicative model, utilizing the restrictions of the
“possible triangle” (Holmans 1993). Such ASP likeli-
hood-ratio methods are based on the comparison of the
observed maximum-likelihood estimates of allele-shar-
ing with allele-sharing proportions derived under the
null hypothesis. Autosomal single-point MLSs were gen-
erated in Genehunter version 2.1, usingMapmaker/SIBS
options (Kruglyak and Lander 1995). X-chromosome
single-point MLS values were generated in Mapmaker/
SIBS. To facilitate combined analysis of the entire data
set, wave 2 alleles were globally binned to ensure that
allele designations were consistent throughout both
waves. All allele frequencies were derived from founders
and random inidividuals in RECODE version 1.4 (Dan
Weeks). Multipoint MLS analysis was performed using
ASPEX 2.3 sib_ibd, with incremental estimates set to
∼1-cM intervals. Values for locus-specific sibling rela-
tive-risk ratios (ls) were calculated from the Z0 param-
eter, assuming a recombination fraction of 0 (l ps
; Risch, 1990). Simulations to determine the em-0.25/Z0
pirical significance of MLS values attained in the current
study were performed using Simulate (Terwilliger et al.
1993). One thousand replicates of the entire autosomal
genome were generated under the null hypothesis of no
linkage, using actual marker parameters (e.g., allele
number and frequency and recombination fraction) and
genotype recovery frequencies. All replicates were ana-
lyzed in ASPEX 2.3, and the resultant MLS values were
analyzed at various thresholds to determine empirical P
values. Exclusion mapping was performed in ASPEX
sib_ibd under defined ls values, assuming no dominance
variance. Any region yielding a LOD score2.00 was
considered excluded. Exclusion mapping compares the
likelihood of the genotype data under the assumption
of specified values of ls with the likelihood under the
null hypothesis of no linkage.
Results
Multipoint MLS Linkage Analysis
Multipoint MLS analysis of the combined data set
yielded six genomic regions with values 11.0 (table 3).
These constitute the six most promising regions for sus-
ceptibility loci within our sample: 5p13, 6q14, 11q25,
16p13, 17p11, and 20q13. Regions 16p13 (MLS p
3.73) and 17p11 (MLS p 2.98) yielded the strongest
evidence for linkage in the present sample. To indicate
relative contributions to the combined MLS values, sep-
arate analyses of wave 1, wave 2, and the combined data
sets are presented (fig. 1). Region 17p11 is the only one
that yields nominal evidence (MLS 10.74; Nyholt 2000)
of linkage in the multipoint analysis of both wave 1
(MLSp 0.79) and wave 2 (MLSp 2.33) data sets. The
sibling relative-risk ratios estimated from the Z0 param-
eter are as follows: 5p13, ls p 1.3; 6q14, ls p 1.4;
11q25, ls p 1.3; 16p13, ls p 1.5; 17p11, ls p 1.5;
and 20q13, ls p 1.2.
Single-Point MLS Linkage Analysis
Single-point MLS analysis in the combined set sup-
ports the multipoint MLS findings for four of the regions
highlighted (table 4). Specifically, single-point MLS val-
ues are 11.0 for markers on 5p13 (D5S418), 6p12-6q14
(D6S257 and D6S460), 16p13 (D16S3047, rs153783,
rs127293, and D16S3060) and 17p11 (D17S799 and
D17S1857). In addition, 11q13 (D11S978) and 15q26
(D15S127) both yielded single-point MLS values 11.0,
but the multipoint MLS values were !1.0. The most
striking single-point MLS was on chromosome 5 at
marker D5S418 (MLS 3.09). D5S418 is the only marker
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Table 3
Regions Yielding Multipoint LOD Scores 11 in MLS Analyses of ASPs with ADHD
LOCATION MLS
CHROMOSOME
NEAREST
MARKER Cytogenetica
Genetic
(cM)b Wave 1c Pd Wave 2 Pd Combined Pd
5 D5S418 5p13 59 .82 .02599 .61 .04686 1.77 .00215
6 D6S460 6q14 79 .19 .17479 2.42 .00042 1.75 .00226
11 D11S1320 11q25 133 .85 .02394 .34 .10541 1.27 .00779
16 D16S3060 16p13 18 3.13 .00007 .50 .06458 3.73 .00002
17 D17S1857 17p11 46 .79 .02824 2.33 .00053 2.98 .00011
20 D20S196 20q13 90 .01 .41504 1.68 .00271 1.19 .00962
a The most likely cytogenetic location of marker, according to draft genome sequence data.
b Distance from the most p-terminal genome-scan marker of the chromosome.
c Subset of families previously reported. The current wave 1 MLS values differ slightly from those published elsewhere
(Fisher et al. 2002), because of additional markers (e.g., 16p13) and the use of ASPEX rather than Genehunter as the analysis
program.
d LOD scores were converted into nominal P values by multiplying by 2loge10 and determining significance from x
2 tables,
taking into account the one-sided nature of the linkage test, as described elsewhere (Lander and Kruglyak 1995).
in the present study that yielded single-pointMLS values
11.0 in both wave 1 (MLS 2.089) and wave 2 (MLS
1.158) data sets.
Exclusion Mapping
Exclusion mapping under a ls of 1.5 excluded 56.3%
of the genome, indicating that the current study lacks
sufficient power to effectively exclude loci with minor-
effect size from approximately half of the genome. Ex-
clusion mapping under a ls of 2.0 excluded 94.3% of
the genome, indicating that it is unlikely that any loci
with a moderate-effect size reside outside 10 discrete
genomic regions: 5p13, 6p21-6q14, 8p23, 8q21, 11q25,
15q26, 16p13, 16q21, 17p11, and 20q13. Under a ls
of 2.5, 99.8% of the genome was excluded, with only
four intervals yielding LOD scores 12.00: 5p13, 6p21-
6q14, 16p13, and 17p11.
Discussion
A genomewide linkage scan in 270 ASPs represents the
largest linkage study in ADHD to date. Previously, our
group reported linkage analysis in an initial set of 126
ASPs (104 families) and identified 12 genomic regions
yielding multipoint MLS values above a defined nominal
threshold of 1.0 (Fisher et al. 2002). We extended the
sample by 144 ASPs (101 families) and foundmultipoint
MLS values 11.0 in six regions, of which three show
support (MLS0.5) in both wave 1 and wave 2 families.
We previously reported a significant linkage of the 16p13
region (MLS 4.22) (Smalley et al. 2002), and we observe
a slight difference (MLS 3.73) in the present study, be-
cause of the incomplete overlap between the two sets of
ASPs.
The current analysis shows that the second strongest
region for linkage is on 17p11, where suggestive evi-
dence (MLS 2.98) is seen in the combined sample and
where support is present in both wave 1 and wave 2
families. An additional region on chromosome 5p13
shows support in wave 1 and wave 2, with a combined
multipoint MLS of 1.77, falling short of suggestive link-
age. The other three regions, 6q14, 11q25, and 20q13,
show support in only one of the two waves of families.
When a nominal LOD threshold of 1.0 is used, the
present sample of 204 families has 190% power to de-
tect susceptibility loci with ls of 1.6 (Risch 1990; Weeks
and Lathrop 1995).
The three regions of strongest linkage in the present
study, 5p13, 16p13, and 17p11, overlap those found in
studies of autism (MIM 209850 and MIM 607373).
Although ADHD and autism are clinically distinct dis-
orders, the symptoms overlap (Smalley et al. 2000). As
discussed elsewhere (Smalley et al. 2002), the region of
16p13 has been highlighted in three independent ge-
nomewide scans (Philippe et al. 1999; InternationalMo-
lecular Genetic Study of Autism Consortium [IMGSAC]
2001; Liu et al. 2001). Interestingly, the 1-LOD support
interval of the new region on 17p11 overlaps the
IMGSAC study (MLS 2.34) (2001), and a QTL analysis
of language-related endophenotypes in the Liu et al.
2001 data set yields additional support for linkage to
autism (Z 13.0; D. Geschwind and M. Alarcon, per-
sonal communication). Lastly, the 5p13 region high-
lighted in the current scan yielded the most significant
evidence of linkage (MLS 2.55) in the Liu et al. (2001)
genomewide scan and yielded nominal evidence (non-
parametric linkage score of 1.65; ) in a secondPp .05
independent linkage study in autism (Buxbaum et al.
2001). The convergence of these three linkage peaks
(16p13, 17p11, and 5p13) in ADHD and autism, as
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well as the overlap for two other regions (7p and 15q)
with autism in an independent ASP linkage study in
ADHD (Bakker et al. 2003), suggests further research
on the overlap is strongly warranted.
The candidate region on 17p is broad, with a 1-LOD
support interval spanning 25 cM and covering 17p11-
17q11. The serotonin transporter gene (5HTT [MIM
182138]) resides on 17q11 beneath the 1-LOD support
described in the present analysis (fig. 1), ∼28 Mb from
the p-telomere and 8 cM from D17S1857 (Marshfield
Center for Medical Genetics; UCSC Genome Bioinfor-
matics). The product of 5HTT is a sodium-calcium–
dependent transporter that clears serotonin from the
synaptic cleft into presynaptic neurons and is believed
to be the site of action of antidepressants and amphet-
amines. Notably, three independent studies have dem-
onstrated association of an insertion-deletion polymor-
phism in the promoter of 5HTT with ADHD (Manor
et al. 2001; Seeger et al. 2001; Kent et al. 2002).
Region 5p13 yielded the third highestmultipoint peak
in the combined data set (MLS 1.77) and is the only
genomic interval yielding nominal evidence of linkage
in both the present study and the Bakker et al. (2003)
linkage scan in ADHD (MLS 1.43). Marker D5S418
yielded a single-point MLS of 3.09 in the combined data
set, the highest single-point MLS in the present study,
and is the only marker yielding single-point MLS values
11.0 in both the wave 1 (MLS 2.089) and wave 2 (MLS
1.158) data sets. Interestingly, glial cell line–derived
neurotrophic factor (GDNF), a gene necessary for the
development of the sympathetic, parasympathetic, and
enteric ganglia, is located in this region. GDNF is a
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Figure 1 MLS values for individual chromosomes. The Y-axis indicates the MLS values and the X-axis indicates the positions in cM.
The dotted line indicates the wave 1 set of families, the thin line represents the wave 2 set, and the thick line represents the combined set. All
graphs begin at 0 cM, which was designated as 10 cM distal to the most p-terminal marker. The current wave 1 MLS values differ slightly
from those reported elsewhere (Fisher et al. 2002), because of the presence of additional markers (e.g., 16p13) and the use of ASPEX, rather
than Genehunter, for the analysis.
protein that is crucial to the development of the pe-
ripheral autonomic nervous system (Pattyn et al. 1999),
and it promotes survival, differentiation, and dopamine
reuptake in dopaminergic neurons (Schaar et al. 1993;
Beck et al. 1995).
The multipoint linkage peak on chromosome 6 (MLS
1.75), the fourth-highest peak in the combined analysis,
contains a 30-cM 1-LOD support interval spanning
6p21-6q14. Although the combined linkage peak is cen-
tered at 6q14, wave 2 single-point MLS values indicate
excess sharing across a 50-cM region spanning 6p22
(D6S422; MLS 1.14) to 6q14 (D6S460; MLS 0.64).
Molecular genetic studies into reading disability (RD
[MIM 600202]), or dyslexia, have converged on a pu-
tative susceptibility locus on 6p21, within the 1-LOD
support interval presented here. A significant propor-
tion of individuals affected with ADHD also have learn-
ing disabilities (Brown et al. 2001), and evidence in-
dicates high rates of comorbidity with RD (Gilger et al.
1992; Semrud-Clikeman et al. 1992; Willcutt and Pen-
nington. 2000). Cardon et al. (1994) first reported the
QTL contributing to RD on 6p21, and genetic studies
in three independent RD samples have produced evi-
dence of linkage to the same region (Fisher et al. 1999;
Gayan et al. 1999; Grigorenko et al. 2000). In addition,
this region on 6p21 has recently been implicated as a
susceptibility locus for ADHD (Willcutt et al. 2002) in
a study of ADHD within sib pairs identified for RD. It
has also been suggested, by another independent linkage
study in RD (Petryshen et al. 2001), that a distinct sus-
ceptibility locus for RD may exist on 6q12.
The 6q region highlighted by the combined analysis
contains two serotonin receptors. Serotonin receptor 1B
is located 85 cM from the p-telomere, directly under
the combined peak. Serotonin receptor 1E is located
∼95 cM from the p-telomere, at the distal edge of the
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Table 4
Markers Yielding Single-Point LOD Scores 11 in MLS Analyses of ASPs with ADHD
LOCATION MLS
CHROMOSOME
AND MARKER
Genetic
(cM)a Cytogeneticb
HETEROZYGOSITYc
(%) Wave 1 Pd Wave 2 Pd Combined Pd
5:
D5S418 61 5p13 84 2.089 .00094 1.158 .01046 3.091 .00008
6:
D6S257 69 6p12 73 .617 .04587 1.581 .00349 1.837 .00181
D6S460 79 6q14 81 .267 .13357 .638 .04327 1.067 .01333
11:
D11S987 64 11q13 88 .137 .21336 1.057 .01369 1.172 .01009
15:
D15S127 76 15q26 81 .444 .07634 1.176 .00998 1.287 .00745
16:
D16S3114 13 16p13 79 1.942 .00139 .043 .32778 1.738 .00233
D16S3047 13 16p13 73 1.741 .00232 .257 .13831 1.501 .00427
rs153783 18e 16p13 36 .645 .04231 1.409 .00543 2.436 .00040
rs127293 18e 16p13 47 1.014 .01536 .253 .14016 1.555 .00373
D16S3060 18 16p13 81 1.268 .00784 .053 .31297 1.421 .00526
17:
D17S799 33 17p12 76 .625 .04493 .477 .06917 1.061 .01355
D17S1857 45 17p11 71 .441 .07708 1.247 .00771 1.326 .00637
NOTE.—Table includes only markers yielding an MLS 11 in the combined data set.
a Distance from the most p-terminal genome-scan marker of the chromosome.
b The most likely cytogenetic location of marker, according to draft genome sequence data (Ensembl and UCSC).
c Heterozygosity of each marker, as estimated from the entire study sample.
d LODs were converted into nominal P values by multiplying by 2loge10 and then determining significance from x
2 tables, taking
into account the one-sided nature of the linkage test, as described elsewhere (Lander and Kruglyak 1995).
e SNP distances are based on physical distances (UCSC Genome Bioinformatics and Celera).
1-LOD support interval. The human leukocyte antigen
(HLA) region resides on 6p21 and is just distal to the
wave 2 1-LOD support interval presented here. Asso-
ciation of ADHD and two genes in the HLA has been
reported; Warren et al. (1995) found association with
the null allele of the C4B gene, and Odell et al. (1997)
reported significant association with both the null allele
of the C4B gene and the b1 allele of the dopamine
receptor gene.
Bakker et al. (2003) present a genomewide scan in a
large independent ADHD sib pair cohort. Notably, their
analyses also revealed nominal evidence for linkage on
5p13 (MLS 1.42); however, the results of MLS analysis
in the two studies showed little concordance for other
regions. The discordance between linkage findings in
the two studies may reflect variation between the clinical
samples in the two studies, the polygenic nature of
ADHD, and/or stochastic fluctuations. There are no-
table differences in the clinical samples. The sample re-
ported by Bakker et al. (2003) consists of fewer indi-
viduals with the inattentive subtype of ADHD (12.6%)
than our sample (45%) ( ), and the Bakker etP ! .0001
al. (2003) broad definition of ADHD includes individ-
uals with clear-cut autism spectrum disorder (33%). In
contrast, all autistic phenotypes are excluded in our
sample. Whether these clinical differences account for
the lack of repeatability of linkage findings across sam-
ples requires additional investigation. The polygenic na-
ture of ADHD suggests that replication of true linkages
will likely require substantially larger samples (Suarez
1994) than those of Bakker et al. (2003) or of the pre-
sent study. A direct comparison of results from the two
studies is complicated by the variability in fine-mapping
data available in each (∼5-cM resolution on 7p13,
9q33, 10cen, and 15q15 in the sample reported by Bak-
ker et al. [2003], and ∼1-cm resolution on 16p13 in our
sample). Linkage signals will vary substantially on the
basis of marker density, as is evident when our own
analysis of the 16p13, using only the 10-cM marker set
(MLS .92), is compared with the dense, ∼1-cM marker
set (MLS 3.73); the variation is due, in part, to increased
information content and inclusion of SNP data. We are
in the process of pooling data across the two samples,
to evaluate the 10-cM dense marker set within a single
large sample and to fine-map a common set of regions
on the basis of these analyses. Lastly, the discordance
across studies may be due to stochastic variation. Some
positive linkage signals within each study are likely to
be false-positive results, and further evaluation of spe-
cific regions within a joint analysis of the two samples,
as well as independent samples, will likely uncover true
signals within the highlighted regions. Notably, the re-
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gion on 5p, which is highlighted in both scans, may
ultimately prove to be a true linkage signal, despite the
finding that the MLS values found for this region in
each study are !2.0. Further support for the possibility
that some of the current peaks are true linkages stems
from simulations (Wiltshire et al. 2003). Simulations
performed within the unique parameters of our data set
demonstrate that the observed number ( ) of in-np 6
dependent regions of linkage at the nominal pointwise
P value .01 (MLS 11.18) is greater than the empirical
expectation ( ). The empirical P value of ob-np 2.8
taining an MLS of 2.98 (17p) is , and that ofPp .03
obtaining an MLS of 3.73 (16p) is , indicatingPp .01
that both are significant. Overall, the variability of find-
ings across the two available genomewide scans in
ADHD reflect the need for larger ASP cohorts and pop-
ulation samples, providing both power to detect loci of
minor effect and coverage of the genetic heterogeneity
present in ADHD.
Exclusion mapping at ls of 1.5 indicates that the cur-
rent study has sufficient power to exclude loci of minor-
effect size from only 56.3% of the genome. Several pro-
posed susceptibility genes in ADHD (e.g., DAT-1 and
DRD4) have estimated effect sizes (genotype relative
risks) that would correspond to ls, !1.5 (Waldman et
al. 1998; Faraone et al. 2001) and would likely not be
detected in the current sample, using an identity-by-
descent sharing methodology. Furthermore, at a ls of
1.5, two of the nine regions highlighted by Bakker et
al. (2003) fall within excluded regions, but under a ls
of 1.4, we cannot exclude any of the nine regions iden-
tified by Bakker et al. (2003). Finally, exclusion map-
ping was performed under an assumption of no dom-
inance variance and should not be overinterpreted
beyond the constraints of the model.
Although the present study indicates that there is un-
likely to be a major-gene effect in ADHD, we have iden-
tified four relatively strong candidate regions on the
basis of linkage findings in the present data set, as well
as reports from other investigations of ADHD (5p13),
comorbid RD (6p21-6q14), and autism (5p13, 16p13,
and 17p11). Replication of the present findings is
needed in larger samples, and fine-mapping is required
to identify allelic variants contributing to susceptibility
to ADHD. The data also highlight possible pleiotropic
effects of putative loci underlying ADHD, autism, and
RD. Until the specific risk loci are identified, it is im-
possible to determine whether the overlap in linkage
peaks reflects pleiotropy or distinct loci in close prox-
imity to one another. However, the emerging pattern of
substantial overlap of regions for these three disorders
is certainly intriguing. Efforts focused on identifying ge-
netic variants that contribute to common phenotypic
presentations across distinct clinical conditions (e.g.,
RD and ADHD) may provide a powerful approach to
gene detection. Furthermore, a neurobiological model
that provides a unifying mechanism of ADHD, au-
tism, and RD, such as variations in cerebral asym-
metry (Geschwind and Miller 2001; Rinehart et al.
2002), may prove useful in ranking potential candidate
genes within chromosome locations suggested by link-
age studies.
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